These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28042328)

  • 1. [
    Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
    Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of
    Kuyumcu S; Isik EG; Tiryaki TO; Has-Simsek D; Sanli Y; Buyukkaya F; Özkan ZG; Kalayoglu-Besisik S; Unal SN
    Ann Nucl Med; 2021 Oct; 35(10):1147-1156. PubMed ID: 34185263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [
    Kosmala A; Duell J; Schneid S; Serfling SE; Higuchi T; Weich A; Lapa C; Hartrampf PE; Raderer M; Einsele H; Buck AK; Topp MS; Schlötelburg W; Werner RA
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):749-755. PubMed ID: 37943339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Chen Z; Yang A; Chen A; Dong J; Lin J; Huang C; Zhang J; Liu H; Zeng Z; Miao W
    Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1926-1936. PubMed ID: 38286937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Lawal IO; Popoola GO; Mahapane J; Kaufmann J; Davis C; Ndlovu H; Maserumule LC; Mokoala KMG; Bouterfa H; Wester HJ; Zeevaart JR; Sathekge MM
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of [
    Liu M; Chen X; Ding H; Shu Q; Zheng Y; Chen Y; Cai L
    Mol Imaging Biol; 2024 Aug; 26(4):658-667. PubMed ID: 38627276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine Receptor-4 Targeted PET/CT Imaging with
    Hadebe B; Harry L; Gabela L; Masikane S; Patel M; Zwane S; Pillay V; Bipath P; Cebekhulu N; Nyakale N; Ramdass P; Msimang M; Aldous C; Sathekge M; Vorster M
    Diagnostics (Basel); 2024 Jun; 14(13):. PubMed ID: 39001265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4-directed PET/CT with [
    Dreher N; Hahner S; Fuß CT; Schlötelburg W; Hartrampf PE; Serfling SE; Schirbel A; Samnick S; Higuchi T; Weich A; Lapa C; Rosenwald A; Buck AK; Kircher S; Werner RA
    Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1383-1394. PubMed ID: 38082196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine Receptor 4-Targeted PET/CT With 68 Ga-Pentixather Detects More Lesions Than 68 Ga-Pentixafor PET/CT in Multiple Myeloma.
    Yang Q; Zhang F; Hao Z; Zhuang J; Huo L
    Clin Nucl Med; 2024 Jun; 49(6):592-593. PubMed ID: 38630995
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Kraus S; Dierks A; Rasche L; Kertels O; Kircher M; Schirbel A; Zovko J; Steinbrunn T; Tibes R; Wester HJ; Buck AK; Einsele H; Kortüm KM; Rosenwald A; Lapa C
    J Nucl Med; 2022 Jan; 63(1):96-99. PubMed ID: 34049979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
    Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
    Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [
    Zhi Y; Werner RA; Schirbel A; Higuchi T; Buck AK; Kosmala A; Bley TA; Hagen R; Hackenberg S; Rosenwald A; Scherzad A; Gerhard-Hartmann E; Serfling SE
    Am J Nucl Med Mol Imaging; 2023; 13(5):208-216. PubMed ID: 38023816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different extramedullary disease shown in chemokine receptor 4 targeted PET/CT with [ 68 Ga]Ga-pentixafor in patients with Waldenström macroglobulinemia and smoldering disease.
    Pan Q; Cao X; Li J; Li F; Luo Y
    Nucl Med Commun; 2024 Aug; 45(8):727-735. PubMed ID: 38745523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI.
    Starzer AM; Berghoff AS; Traub-Weidinger T; Haug AR; Widhalm G; Hacker M; Rausch I; Preusser M; Mayerhoefer ME
    Clin Nucl Med; 2021 Jan; 46(1):16-20. PubMed ID: 33208624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated Whole-Body Bone Lesion Detection for Multiple Myeloma on
    Xu L; Tetteh G; Lipkova J; Zhao Y; Li H; Christ P; Piraud M; Buck A; Shi K; Menze BH
    Contrast Media Mol Imaging; 2018; 2018():2391925. PubMed ID: 29531504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68 Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results.
    Waheed A; Singh B; Watts A; Kaur H; Singh H; Dhingra K; Ahuja C; Madan R; Singh A; Radotra BD
    Clin Nucl Med; 2024 Apr; 49(4):e141-e148. PubMed ID: 38350065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68 Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results.
    Jena SR; Watts A; Aggarwal P; Bachhal V; Kaur H; Dhingra K; Singh H; Bal A; Singh B
    Nucl Med Commun; 2024 Mar; 45(3):229-235. PubMed ID: 38165171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in PET Imaging of the CXCR4 Receptor: [
    Lindenberg L; Ahlman M; Lin F; Mena E; Choyke P
    Semin Nucl Med; 2024 Jan; 54(1):163-170. PubMed ID: 37923671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4.
    Yang T; Shi D; Lin Q; Shen H; Tan H; Liu Y; Shi H; Cheng D
    Mol Pharm; 2024 May; 21(5):2415-2424. PubMed ID: 38606663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4-Targeted 68 Ga-Pentixafor PET/CT Imaging in Inflammatory Bowel Disease.
    Chen Y; Yuan H; Tan X; Shang Y; Sun X; Wang P; Jiang L
    Clin Nucl Med; 2024 Sep; 49(9):817-821. PubMed ID: 39086048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.